Century Therapeutics
IPSC
63 hedge funds and large institutions have $58.7M invested in Century Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 7 closing their positions.
1,500% more call options, than puts
Call options by funds: $16K | Put options by funds: $1K
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
63% more capital invested
Capital invested by funds: $36.1M → $58.7M (+$22.6M)
15% more funds holding
Funds holding: 55 → 63 (+8)
5% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 20
0.66% less ownership
Funds ownership: 30.22% → 29.56% (-0.66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.94M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$467K |
| 3 |
Millennium Management
New York
|
+$253K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$87.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$75.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.66M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1.09M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$641K |
| 4 |
BlackRock
New York
|
-$139K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$128K |
IPSC Hedge Fund Activity: Q4 2023 in Review
63 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q4 2023, worth a combined $58.7M — up 63% from $36.1M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IPSC positions and 7 closed out — a net gain of 8 holders — while 21 added to existing stakes and 20 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $1.94M. The largest seller was Fidelity Investments, cutting an estimated $1.66M.
- 63 institutional investors held Century Therapeutics (IPSC) as of Q4 2023, up from 55 in Q3 2023.
- Funds reported $58.7M of Century Therapeutics stock for Q4 2023, up 63% quarter-over-quarter.
- 15 funds opened new Century Therapeutics positions in Q4 2023 and 7 closed out, a net change of +8 holders.
- The largest Century Therapeutics buyer in Q4 2023 was Tang Capital Management, an estimated $1.94M added.
- The largest Century Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $1.66M sold.
Based on aggregated 13F filings for Q4 2023.